Trilogy Capital’s Microchip Technology MCHP Stock Holding History

Trilogy Capital’s Portfolio MCHP Stock Details MCHP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.3M	Sell	42,457 -2,811	-6%	-$219K	0.13%	133
2026 Q2	$4.13M	Sell	45,268 -661	-1%	-$58.9K	0.16%	105
2026 Q1	$2.97M	Sell	45,929 -415	-0.9%	-$29.8K	0.13%	126
2025 Q4	$2.95M	Buy	46,344 +6,910	+18%	+$426K	0.13%	132
2025 Q3	$2.53M	Sell	39,434 -894	-2%	-$60.6K	0.12%	128
2025 Q2	$2.84M	Sell	40,328 -11,519	-22%	-$633K	0.14%	118
2025 Q1	$2.51M	Buy	51,847 +16,628	+47%	+$926K	0.13%	117
2024 Q4	$2.02M	Buy	+35,219	New	+$2.42M	0.1%	143

Other funds holding MCHP

Fenimore Asset Management Cobleskill, New York $4.55B AUM 5.53% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Godsey & Gibb Inc Richmond, Virginia $1.21B AUM 18.94% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Hosking Partners London, United Kingdom $2.81B AUM 67.07% 1-Year Est. Return

E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return

Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Trilogy Capital's MCHP Position: Q3 2026 in Review

Trilogy Capital reduced its Microchip Technology (MCHP) stake by 6.2% in Q3 2026, selling an estimated $219K and leaving 42,457 shares worth $3.3M. The position accounts for 0.13% of the portfolio, ranked #133.

Trilogy Capital first reported a position in MCHP in Q4 2024 and has held it in 8 quarters since. The position peaked at $4.13M in Q2 2026. 314 funds tracked by Wall St. Rank hold MCHP as of Q3 2026.

Trilogy Capital held 42,457 shares of Microchip Technology worth $3.3M as of Q3 2026.
Trilogy Capital sold 2,811 Microchip Technology shares in Q3 2026, an estimated $219K.
Microchip Technology made up 0.13% of Trilogy Capital's portfolio in Q3 2026, its #133 holding.
Trilogy Capital first reported a position in Microchip Technology in Q4 2024 and has held it in 8 quarters since.
Trilogy Capital's Microchip Technology position peaked at $4.13M in Q2 2026.
314 funds tracked by Wall St. Rank held Microchip Technology as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.